Improving Patient Outcomes in Adult Asthma
A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive of the live webinars held March 25, 2010 and March 31, 2010. If you participated in the live activity, you are not eligible for continuing education credits from this archive.

This activity is valid from June 22, 2010 to December 31, 2010.
 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by educational grants from AstraZeneca
PLEASE CLICK HERE TO VIEW PRESENTATION

 PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit to keads@namcp.org.  A score of 70% must be achieved on the post test to receive continuing education credits. You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Description
22 million Americans have a current diagnosis of asthma. Every year patients with asthma have an estimated 12 million asthma attacks, 2 million emergency room visits, and approximately 4000 asthma-related deaths, according to the CDC. Asthma has a significant impact on both the healthcare system and healthcare consumers. The annual direct and indirect costs have exceeded approximately $18 billion according to the Asthma and Allergy Foundation. It is for this reason that the healthcare system must take action to reduce expenditures for asthma, while increasing quality of care in the patient population. Effective and timely treatment of asthma can both improve patient outcomes and reduce the cost when following these guidelines set forth by NAEPP.


Objectives

  • Understand the epidemiology and public health burden of asthma

  • Determine the implications and costs associated with the treatment of asthma in Managed Care

  • Discuss the pharmacoeconomics of asthma therapy as it relates to clinical outcomes

  • Use NAEPP Guidelines to determine the course of treatment options and assess patient response to therapy

  • Integrate open communication and set patient goals collaboratively in clinical practice to improve patient adherence

Faculty: Gary M. Owens, MD
President, Gary Owens Associates
   

Disclosure:

 Dr. Owens discloses that he has received honoraria for serving as a consultant to Amgen, AstraZeneca, Asthmatx, Biosense Webster, Eli Lilly and Company, Genentech, and Schering-Plough Corporation; has served on the speakers' bureau for Genentech; and has conducted market research for AstraZeneca.
  The NAMCP planning committee has no real or perceived financial relationships to disclose.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA) VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

  

This activity is supported by educational grants from AstraZeneca